Overview
HemostOD SA is a Swiss biotechnology company specializing in the ex vivo production of universal human blood platelets. Their innovative platform aims to address global platelet shortages by manufacturing engineered platelets from immortalized hematopoietic stem cells.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Hemostod Sa in our records. PharmaTek screens the full directory against live FDA enforcement data.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.